EGFR and non-small cell lung carcinoma: In Caucasian patients with non-squamous NSCLC, mutations in the EGFR gene are found in 10–15% of cases, ALK gene rearrangement—in 4.5–7.5% of cases, ROS1 gene rearrangement—in 1.5–2% of cases.